Production of anti-CD14 monoclonal antibodies using CD14 expressing COS cells as immunizing antigen

S Moonsom1, W Kasinrerk

  • 1Department of Clinical Immunology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.

Insights

Researchers developed a novel method to create monoclonal antibodies (MAbs) targeting the CD14 molecule, crucial for identifying monocytes and understanding endotoxin responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Biotechnology

Background:

  • CD14 is a leukocyte surface molecule primarily on monocytes.
  • CD14 acts as a receptor for bacterial endotoxin.
  • Monoclonal antibodies (MAbs) against CD14 are valuable for cell identification and studying immune responses.

Purpose of the Study:

  • To develop an efficient method for producing CD14-specific MAbs.
  • To utilize a novel antigen preparation strategy for MAb generation.
  • To characterize the specificity and function of newly generated CD14 MAbs.

Main Methods:

  • Generated CD14-expressing COS cells using cDNA and expression systems.
  • Immunized mice with CD14-expressing cells.
  • Fused spleen cells with myeloma cells to create hybridomas.
  • Screened hybridomas for CD14-specific antibody production.

Main Results:

  • Successfully generated 5 hybridoma clones secreting CD14-specific MAbs.
  • The MAbs showed strong reactivity with monocytes, weak with neutrophils, and no reactivity with lymphocytes.
  • The generated MAbs inhibited lipopolysaccharide (LPS) binding to CD14.
  • The MAbs can be used for enumerating peripheral blood monocytes.

Conclusions:

  • An alternative and effective antigen preparation method for MAb production against cell surface molecules was established.
  • The novel CD14 MAbs are suitable for identifying monocytes and studying endotoxin interactions.
  • This approach offers a valuable tool for immunological research and diagnostics.